powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1740501311
Brian Clark
M.D.
Pulmonary Disease
New Haven,
CT
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
PRESCRIBING · PART D · 2024
Total Rx claims
781
Beneficiaries
—
Total drug cost
$853K
Distinct drugs
17
Brand share
85.1%
Top prescribed drugs
Fluticasone/Umeclidin/Vilanter
129 claims
Fluticasone/Vilanterol
126 claims
Albuterol Sulfate
96 claims
Dupilumab
65 claims
Montelukast Sodium
62 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
251
Unique beneficiaries
—
Total services
320
Distinct HCPCS
8
Medicare payment
$20K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 210 Pulmonary Disease providers in CT — below median (cohort median 666).
QUALITY · MIPS · 2024
Final MIPS score
87.4
Quality
77.4
Cost
74.3
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.52%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$125
Payment records
1
By payment type
Food and Beverage
$125
Top paying entities
Food and Beverage
$125
